Technical Analysis for NLSP - NLS Pharmaceutics Ltd.

Grade Last Price % Change Price Change
F 0.27 -12.69% -0.04
NLSP closed down 12.69 percent on Monday, March 18, 2024, on 9.07 times normal volume. The bears made the stock sink to a new 52-week low.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New Downtrend Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Down 1 ATR about 12 hours ago
2x Volume Pace about 12 hours ago
3x Volume Pace about 12 hours ago
10x Volume Pace about 12 hours ago
Fell Below Previous Day's Low about 12 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neurological Disorders Psychiatric Diagnosis Psychiatry Sleep Disorders Attention Deficit Hyperactivity Disorder Drug Therapies Narcolepsy Amphetamine Methylphenidate Adhd Cataplexy Idiopathic Hypersomnia

Is NLSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.6
52 Week Low 0.2197
Average Volume 61,329
200-Day Moving Average 0.68
50-Day Moving Average 0.43
20-Day Moving Average 0.36
10-Day Moving Average 0.34
Average True Range 0.06
RSI (14) 24.81
ADX 26.59
+DI 9.44
-DI 31.00
Chandelier Exit (Long, 3 ATRs) 0.32
Chandelier Exit (Short, 3 ATRs) 0.39
Upper Bollinger Bands 0.44
Lower Bollinger Band 0.29
Percent B (%b) -0.11
BandWidth 42.88
MACD Line -0.04
MACD Signal Line -0.03
MACD Histogram -0.005
Fundamentals Value
Market Cap 9.62 Million
Num Shares 35.7 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -0.54
Price-to-Sales 0.00
Price-to-Book 4.84
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.46
Resistance 3 (R3) 0.47 0.41 0.43
Resistance 2 (R2) 0.41 0.36 0.41 0.42
Resistance 1 (R1) 0.34 0.33 0.31 0.33 0.41
Pivot Point 0.28 0.28 0.26 0.28 0.28
Support 1 (S1) 0.21 0.23 0.18 0.21 0.13
Support 2 (S2) 0.15 0.20 0.15 0.12
Support 3 (S3) 0.08 0.15 0.11
Support 4 (S4) 0.08